Tag: License
Pluristem’s Point-Of-Care Thawing Device To Be Manufactured And Distributed By Chart Industries
Pluristem Therapeutics Inc., has announced that it has entered into a license agreement with a subsidiary of Chart Industries, Inc., regarding Pluristem’s thawing device for cell-based therapies. Pluristem Therapeutics Inc., founded in 2003, headquartered in Haifa, Israel, is a...
Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy
Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Asterias is presently focused on advancing three clinical-stage programs which have the potential to...
Biotime Has Licensed One Of Its Pluripotent Cell Lines To GoLiver
BioTime Inc. is a clinical-stage biotechnology company, headquartered in the San Francisco Bay Area, focused on degenerative diseases. Its clinical programs are based on two platform technologies: cell replacement and cell/drug delivery. With its cell replacement platform, BioTime is...
STEMCELL Technologies Licenses Inner Ear Organoid Culture Technique
The ability to hear music and keep balanced when upright is dependent on mechanosensory “hair cells” in the inner ear that convert vibrations into electrical signals . They are located inside the organ of Corti within the snail-shaped cochlea...
